IFNA1 and chronic hepatitis B virus infection: Interferon-α was the first approved medication for chronic hepatitis B. Both standard interferon-α (IFN-α), and later in 2005, the long-acting Pegylated interferon-α (Peg IFN-α) have both immunomodulatory and antiviral effects [32].